Products

IQVIA Patient Finder Solution / Site
IQVIA
Drug Discovery & Research
IQVIA Patient Finder Solution and Site Suite leverage AI and real-world EHR data to accelerate patient recruitment and streamline clinical trial management for research staff and investigators.

See all 1 product →

About IQVIA

IQVIA is a leading global provider of advanced analytics, technology solutions, and clinical research services, dedicated to leveraging human data science and artificial intelligence to accelerate innovation in healthcare. For physicians, IQVIA’s ‘Connected Intelligence™’ approach integrates unparalleled data, advanced analytics, and ‘Healthcare-grade AI®’ to deliver actionable insights across the entire healthcare ecosystem. This enables a deeper understanding of diseases, patient journeys, and treatment pathways, supporting more informed clinical decision-making and improved patient outcomes.

The company’s AI-powered capabilities are designed to enhance various aspects of healthcare, from accelerating drug development and clinical trials to optimizing commercial strategies and real-world evidence generation. Physicians can benefit from tools that aid in patient finding and disease modeling, predictive AI for identifying at-risk populations, and clinical decision support systems. IQVIA is committed to responsible AI use, ensuring solutions meet high standards of privacy, regulatory compliance, and patient safety, thereby fostering trust and precision in life sciences and healthcare applications.

What Physicians Need to Know

Clinical Development & Research
IQVIA's AI tools accelerate clinical trials by improving study design, patient recruitment, and site risk assessments. They identify outliers in lab tests and vital signs, and predict patient eligibility for early treatment, ultimately aiming to reduce costs and timelines.
Commercialization & Marketing
The company enhances commercial effectiveness through precision HCP (Healthcare Professional) and patient engagement. Their AI optimizes marketing return on investment, enables targeted physician outreach, and provides real-time engagement tracking and digital product launch support.
Real-World Evidence (RWE) & Medical Affairs
IQVIA leverages AI for generating real-world evidence, understanding complex treatment pathways, and patient profiling. This includes identifying undiagnosed patients, supporting medical affairs initiatives, and profiling Key Opinion Leaders (KOLs) for scientific communication.
Data Management & Analytics
They specialize in streamlining data discovery and management, utilizing vast healthcare data assets including over 1.2 billion patient records, 150,000+ data suppliers, and 61+ petabytes of unique data. Their solutions provide advanced analytics, AI-driven automation, and decision support.
Pharmacovigilance & Regulatory Compliance
IQVIA's AI simplifies pharmacovigilance processes, automating the identification of adverse events and risks. They also streamline regulatory information management (RIM) and enhance quality compliance (eQMS) with next-generation technologies.
Physician Tip

For physicians, IQVIA's AI tools are designed to significantly improve patient care by enabling earlier diagnoses, identifying patients ready for treatment, and predicting uncontrolled illnesses with greater precision. Their clinical decision support tools empower healthcare professionals with simplified health data, leading to more informed decisions and valuable patient conversations. The AI-driven platforms streamline administrative workflows, reduce delays, and free up physicians' time for higher-value patient interactions. Furthermore, IQVIA's commitment to 'Healthcare-grade AIu00ae' ensures that these solutions operate securely and align with stringent healthcare regulatory and privacy standards, fostering trust in the technology. Physicians can also benefit from personalized engagement strategies and access to actionable insights that provide a comprehensive understanding of treatment pathways and patient journeys.

IQVIA's core technology stack includes their unified agentic AI platform, IQVIA.ai, which integrates with NVIDIA technologies such as Nemotron, NeMo Agent Toolkit, Dynamo, and LangChain. They leverage their proprietary 'Connected Intelligenceu2122' for data assets and have named AWS as their preferred agentic cloud provider. The platform is built to embed intelligence directly into workflows, offering both ready-to-use and configurable intelligent agents designed around real-world life sciences workflows.

Products by IQVIA

1 product in the directory

IQVIA Patient Finder Solution / Site
IQVIA
Drug Discovery & Research
IQVIA Patient Finder Solution and Site Suite leverage AI and real-world EHR data to accelerate patient recruitment and streamline clinical trial management for research staff and investigators.

What the Web Says

IQVIA is a global provider of advanced analytics, technology solutions, and clinical research services to the life sciences and healthcare industries. Product reviews highlight a user-friendly interface and accurate data for market analysis and healthcare insights. Employer reviews are mixed, with some praising the work-life balance and benefits, while others cite low pay, toxic work environments, and frequent layoffs.

Overall: Mixed

Strengths

  • User-friendly interface for building queries and accessing data.
  • Provides accurate and detailed healthcare data for market analysis and decision-making.
  • Offers AI-powered solutions and advanced analytics for the healthcare sector.
  • Good work-life balance and remote positions are available for some roles.
  • Comprehensive solutions for managing clinical trials, regulatory information, and hospital operations.
  • Opportunities for learning and professional development in some departments.

Limitations

  • Data limitations can occur, particularly with government information.
  • Some employees report a chaotic work environment and high workload.
  • Salaries are sometimes below market standard, and promotion can be difficult.
  • Concerns about job security due to frequent layoffs and outsourcing.
  • Toxic work culture and unsupportive management in certain areas.
  • Lengthy and stressful hiring process, with some candidates experiencing unprofessional conduct.

Based on reviews from: G2, Glassdoor, Reddit, Indeed.com, Gartner Peer Insights, Comparably, Capterra, FeaturedCustomers

Last updated: 2026-08-22

Videos

News, demos, and interviews about IQVIA.

Loading videos...

Videos load interactively. If none appear, search YouTube for IQVIA →

View all on YouTube

Press & Coverage

IQVIA Investor Relations
IQVIA and Medera to Advance Cardiac Gene Therapy and Human-Based Drug Discovery
IQVIA and Medera Inc. announced a collaboration to advance cardiac gene therapy and human-based drug discovery, leveraging IQVIA's clinical research services and Medera's pioneering biopharmaceutical work.
2026-08
IQVIA Investor Relations
IQVIA Reports Second-Quarter 2026 Results
IQVIA reported strong second-quarter 2026 results, with revenue of $4.37 billion, an 8.7% year-over-year increase, and adjusted diluted earnings per share of $3.15, exceeding analyst expectations.
2026-07
BioSpace
IQVIA's AI-Enabled Clinical Decision Support Tool Wins 2026 AI Breakthrough Award for Predictive Modeling Solution of the Year
IQVIA's AI-enabled Clinical Decision Support Tool, developed with Breakthrough T1D, won the 2026 AI Breakthrough Award for Predictive Modeling Solution of the Year for its effectiveness in diagnosing Type 1 Diabetes.
2026-08
Investing.com
Iqvia Holdings stock hits 52-week high at $260.32
IQVIA Holdings Inc. stock reached a 52-week high of $260.32, reflecting a 38% appreciation over the past year and strong investor confidence following positive second-quarter results.
2026-08
IQVIA Investor Relations
IQVIA Unveils IQVIA.ai, a Unified Agentic AI Platform Powered by NVIDIA to Improve Efficiency and Decision Making Across Life Sciences
IQVIA launched IQVIA.ai, a unified agentic AI platform powered by NVIDIA, designed to enhance efficiency and decision-making throughout the life sciences industry.
2026-03
PMC (PubMed Central)
Real-World Cardiovascular Research Using the German IQVIA Disease Analyzer Database: Methods, Evidence, and Limitations (2000u20132025)
This peer-reviewed article synthesizes evidence from 13 studies (2020-2025) utilizing the German IQVIA Disease Analyzer database for real-world cardiovascular research, demonstrating its value in identifying associations between risk factors and outcomes.
2026-01
IQVIA Investor Relations
IQVIA Announces Pricing of Senior Notes
IQVIA announced the pricing of senior notes, following an earlier announcement of an offering of senior notes, indicating financial activity and potential capital raising.
2026-06
IQVIA Institute for Human Data Science
IQVIA Institute's Global R&D Trends 2026 Report Finds Credible Signal on AI-Enabled Programs
The IQVIA Institute's Global R&D Trends 2026 report highlights early evidence of stronger success rates for AI-enabled programs among emerging biopharma companies, exploring AI's application in drug discovery and development.
2026-03

Frequently Asked Questions

IQVIA offers a unified agentic AI platform, IQVIA.ai, designed to improve efficiency and decision-making across clinical, commercial, and real-world domains. This includes AI-driven automation, advanced analytics, and decision support, with specific solutions like AI Patient & HCP Profiling and the IQVIA Vigilance Platform for pharmacovigilance.
IQVIA is committed to 'Healthcare-grade AI' and responsible AI practices, operating securely and in alignment with healthcare regulatory, privacy, and quality standards, including HIPAA and GDPR. They employ a wide range of privacy-enhancing technologies, safeguards, and a global privacy policy to protect individual patient privacy.
IQVIA does not publicly disclose specific pricing information for its data services and AI solutions. Organizations interested in their AI-driven healthcare solutions are advised to contact IQVIA directly to obtain current pricing and discuss options tailored to their specific needs.
IQVIA provides tailored support for the successful integration and optimization of its AI/ML technologies, leveraging its team of data scientists and strategy consultants. Their platforms are designed to embed intelligence directly into existing workflows and integrate with current IT environments, ensuring smooth adoption and operational efficiency.
Yes, IQVIA has strategic partnerships with key technology leaders such as NVIDIA and AWS to power its next-generation agentic AI platform, and with Microsoft and OpenAI for generative AI capabilities. These collaborations enhance IQVIA's AI offerings, accelerating research, clinical development, and commercialization for its healthcare clients.
IQVIA, a Fortune 500 company, has a long-term vision of 'powering smarter healthcare for everyone, everywhere' and is deeply committed to AI innovation. They continuously invest in this space, evidenced by over 100 AI-related patent filings and a focus on responsible AI development to ensure sustained viability and innovation of their products.
IQVIA employs a research-led, three-step process to identify, report, and mitigate bias in AI training data and algorithm output. They emphasize human oversight ('experts in the loop'), transparency, and continuous evaluation to ensure fairness, accuracy, and explainability of AI-driven insights for diverse patient populations.

Related Companies

QuickIntell is an AI-first healthcare technology company dedicated to transforming healthcare operations for physicians and healthcare providers. The company leverages advanced AI agents, including Computer Vision, Machine Learning, Optical Character Recognition (OCR), and Natural Language Processing (NLP), to streamline administrative workflows and enhance Revenue Cycle Management (RCM). QuickIntell’s solutions are designed to reduce administrative burden, […]

Ease Tax Relief, founded in 2016, is a tax relief and resolution company based in Harleysville, PA. The company specializes in helping individuals and small businesses resolve issues with the IRS, offering services such as Offer in Compromise, Partial Pay Installment Agreements, Payment Plans, and Penalty Reduction. Owned and operated by Zheng Yang, a CPA […]

CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]

Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]

OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]

Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.